From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.
Hum Gene Ther Clin Dev
; 24(2): 86-98, 2013 Jun.
Article
in En
| MEDLINE
| ID: mdl-23845071
Full text:
1
Database:
MEDLINE
Main subject:
Gammaretrovirus
/
Genetic Vectors
/
Granulomatous Disease, Chronic
Type of study:
Clinical_trials
Limits:
Animals
/
Humans
Language:
En
Year:
2013
Type:
Article